Compounds > nitroglycerin

nitroglycerin and carboplatin

nitroglycerin has been researched along with carboplatin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K1
Aerts, JG; Bahce, I; Biesma, B; Burgers, JA; Dingemans, AM; Groen, HJ; Herder, GJ; Smit, EF; Stigt, JA; van den Borne, BE; van der Noort, V; Vincent, A1
Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W1
de Jong, EEC; Degens, JHRJ; Deist, TM; Dingemans, AC; Jochems, A; Lambin, P; Leijenaar, RTH; Sanders, KJC; Schols, AMWJ; van Elmpt, W; van Timmeren, JE1

Trials

4 trial(s) available for nitroglycerin and carboplatin

ArticleYear
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Nitroglycerin; ROC Curve; Taxoids; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2006
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitroglycerin; Paclitaxel

2015
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents

2017
Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 120

    Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Nitroglycerin; Paclitaxel; Survival Rate; Tomography, X-Ray Computed

2019